Sort
30,917 grants matching “tumor microenvironment”
Early phase clinical trial for imaging tumor acidosis in breast cancer patients using acidoCEST MRI
$351,036Julio Cardenas-Rodriguez · University Of Arizona · R01 · FY2016 · CA
Novel Molecular Targeted Radionuclide Therapies for Dosimetry-Guided Immunomodulation
$351,030Jamey P Weichert · University Of Wisconsin-Madison · P01 · FY2023 · CA
Novel Molecular Targeted Radionuclide Therapies for Dosimetry-Guided Immunomodulation
$351,029Jamey P Weichert · University Of Wisconsin-Madison · P01 · FY2022 · CA
Role of ER-membrane contacts in biogenesis of RNA-containing EVs
$351,002Alissa M Weaver · Vanderbilt University · P01 · FY2021 · CA
Drivers of metabolic plasticity promote radiation resistance in glioblastoma multiforme
$351,000Erina Vlashi · University Of California Los Angeles · R01 · FY2023 · CA
Disrupting tumor/bone malignant interactions with multifunctional cytokine sonodelivery
$350,990Marxa L. Figueiredo · Purdue University · R01 · FY2019 · CA
The Role of Egfl6 in Tumor Immunity
$350,974Sandra Cascio · Magee-Women'S Res Inst And Foundation · R01 · FY2023 · CA
Mining B-catenin/BCL9 transcriptional complex for Multiple Myeloma therapeutics
$350,957Ruben D Carrasco · Dana-Farber Cancer Inst · R01 · FY2010 · CA
Replication stress response defects predict and enhance immune checkpoint therapy response in triple negative breast cancer
$350,935Shiaw-Yih Lin · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Aim/Project 1. Dose-response at single-cell and population levels
$350,854Peter Karl Sorger · Harvard Medical School · P50 · FY2018 · GM
Engineering S. typhimurium for metastatic colorectal cancer
$350,841Tal Danino · Columbia Univ New York Morningside · R01 · FY2022 · EB
Metabolic Reprogramming of Tumor Infiltrating Lymphocytes for Adoptive Immunotherapy
$350,834Udai S Kammula · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · CA
Metabolic Reprogramming of Tumor Infiltrating Lymphocytes for Adoptive Immunotherapy
$350,834Udai S Kammula · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA
CXCL5/CXCR2 axis as a therapeutic vulnerability of breast cancer metastasis to bone
$350,834Laurie E Littlepage · University Of Notre Dame · R01 · FY2022 · CA
Targeting TIGIT and PD-1 in Melanoma
$350,834Hassane M Zarour · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · CA
Role of ICAM1 in development and progression of pancreatic cancer
$350,834Peter Storz · Mayo Clinic Jacksonville · R01 · FY2023 · CA
Role of ICAM1 in development and progression of pancreatic cancer
$350,834Peter Storz · Mayo Clinic Jacksonville · R01 · FY2022 · CA
Extracellular vesicle RNA signaling in liver tumor microenvironment
$350,834Tushar Patel · Mayo Clinic Jacksonville · R01 · FY2022 · CA
CXCL5/CXCR2 axis as a therapeutic vulnerability of breast cancer metastasis to bone
$350,834Laurie E Littlepage · University Of Notre Dame · R01 · FY2023 · CA
Mechanisms Controlling Cellular Differentiation and Proliferation in a Plant Stem Cell Microenvironment
$350,820Naden Krogan · American University · R15 · FY2015 · GM
Computational model of targeted drug delivery
$350,791Dieter Haemmerich · Medical University Of South Carolina · R01 · FY2023 · CA
Project 4: Thymic and peripheral Aspects of T cell Aging and Rejuvenation
$350,753Janko Nikolich-Zugich · University Of Arizona · P01 · FY2021 · AG
Leveraging biological insights to enhance immunotherapies
$350,734Robbie G. Majzner · Children'S Hosp Of Philadelphia · P01 · FY2024 · CA
Core C: CODEX Core
$350,708Garry P Nolan · Stanford University · P01 · FY2021 · CA
Project 3: Increasing the potency and accessibility of EBVSTs for the treatment of Lymphoma
$350,699Cliona M Rooney · Baylor College Of Medicine · P50 · FY2023 · CA